Verrica Pharmaceuticals (VRCA)

• Market cap: $44.8M
• 1 day: 12.11%
• 5 days: 21.96%
• 1 month: 22.6%
• 3 months: -21.2%
• 6 months: -17.63%
• Year to date: -32.86%
• 1 year: -52.37%
• 5 years: -95.08%
• 10 years: -97.3%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71